Questcor Therapeutics (QCOR) spikes lower on increasing volume of 1.8 million shares and is down $3.05 to $54.59 (falling fast) on a negative report from Citron Research — saying it will be a single digit stock in 18 months (Here’s the link — LINK). Shares are volatile and options volume is picking up, with 5,600 puts and 2,290 calls traded in the name so far. July 50 and 55 puts are the most actives and 30-day ATM vols moved up 9.5 precent to 56.5.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.